BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 30578871)

  • 1. IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Ailal F; Bousfiha A; Deswarte C; Oleaga-Quintas C; Casanova JL; Bustamante J; Liston A
    J Allergy Clin Immunol; 2019 Jun; 143(6):2215-2226.e7. PubMed ID: 30578871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Bornschein S; Cauwe B; Schönefeldt S; Bossuyt X; Matthys P; Baron F; Wouters C; Liston A
    J Allergy Clin Immunol; 2016 Jul; 138(1):200-209.e8. PubMed ID: 26947179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.
    Rood JE; Rao S; Paessler M; Kreiger PA; Chu N; Stelekati E; Wherry EJ; Behrens EM
    Blood; 2016 Jan; 127(4):426-35. PubMed ID: 26518437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trigger-dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis.
    Gather R; Aichele P; Goos N; Rohr J; Pircher H; Kögl T; Zeiser R; Hengel H; Schmitt-Gräff A; Weaver C; Ehl S
    Eur J Immunol; 2020 Nov; 50(11):1770-1782. PubMed ID: 32419134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
    Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
    J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation.
    Tsoukas P; Rapp E; Van Der Kraak L; Weiss ES; Dang V; Schneider C; Klein E; Picarsic J; Salcedo R; Stewart CA; Canna SW
    Blood; 2020 Nov; 136(19):2162-2174. PubMed ID: 32589707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations.
    Ghosh S; Carmo M; Calero-Garcia M; Ricciardelli I; Bustamante Ogando JC; Blundell MP; Schambach A; Ashton-Rickardt PG; Booth C; Ehl S; Lehmberg K; Thrasher AJ; Gaspar HB
    J Allergy Clin Immunol; 2018 Sep; 142(3):904-913.e3. PubMed ID: 29355678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.
    Das R; Guan P; Sprague L; Verbist K; Tedrick P; An QA; Cheng C; Kurachi M; Levine R; Wherry EJ; Canna SW; Behrens EM; Nichols KE
    Blood; 2016 Mar; 127(13):1666-75. PubMed ID: 26825707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations.
    Wada T; Sakakibara Y; Nishimura R; Toma T; Ueno Y; Horita S; Tanaka T; Nishi M; Kato K; Yasumi T; Ohara O; Yachie A
    Hum Immunol; 2013 Dec; 74(12):1579-85. PubMed ID: 24051121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Deficiency of Interferon-γ Reveals Interferon-γ-Independent Manifestations of Murine Hemophagocytic Lymphohistiocytosis.
    Burn TN; Weaver L; Rood JE; Chu N; Bodansky A; Kreiger PA; Behrens EM
    Arthritis Rheumatol; 2020 Feb; 72(2):335-347. PubMed ID: 31400073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease.
    Kögl T; Müller J; Jessen B; Schmitt-Graeff A; Janka G; Ehl S; zur Stadt U; Aichele P
    Blood; 2013 Jan; 121(4):604-13. PubMed ID: 23190531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis.
    Albeituni S; Oak N; Tillman HS; Stroh A; Keenan C; Bloom M; Nichols KE
    Front Immunol; 2023; 14():1137037. PubMed ID: 37228616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation.
    Landy E; Varghese J; Dang V; Szymczak-Workman A; Kane LP; Canna SW
    Blood Adv; 2023 Nov; 7(22):6949-6963. PubMed ID: 37738167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire.
    Ammann S; Lehmberg K; Zur Stadt U; Janka G; Rensing-Ehl A; Klemann C; Heeg M; Bode S; Fuchs I; Ehl S;
    Eur J Immunol; 2017 Feb; 47(2):364-373. PubMed ID: 27925643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis.
    Albeituni S; Verbist KC; Tedrick PE; Tillman H; Picarsic J; Bassett R; Nichols KE
    Blood; 2019 Jul; 134(2):147-159. PubMed ID: 31015190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis.
    Brisse E; Imbrechts M; Mitera T; Vandenhaute J; Berghmans N; Boon L; Wouters C; Snoeck R; Andrei G; Matthys P
    Clin Exp Immunol; 2018 Apr; 192(1):104-119. PubMed ID: 29178470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perforin is a critical physiologic regulator of T-cell activation.
    Lykens JE; Terrell CE; Zoller EE; Risma K; Jordan MB
    Blood; 2011 Jul; 118(3):618-26. PubMed ID: 21606480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice.
    Sepulveda FE; Maschalidi S; Vosshenrich CA; Garrigue A; Kurowska M; Ménasche G; Fischer A; Di Santo JP; de Saint Basile G
    Blood; 2015 Feb; 125(9):1427-34. PubMed ID: 25525117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.
    Johnson TS; Terrell CE; Millen SH; Katz JD; Hildeman DA; Jordan MB
    J Immunol; 2014 Jan; 192(1):84-91. PubMed ID: 24259502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis.
    Brisse E; Imbrechts M; Mitera T; Vandenhaute J; Wouters CH; Snoeck R; Andrei G; Matthys P
    Virol J; 2017 Dec; 14(1):240. PubMed ID: 29258535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.